Dopamine/glutamate interaction as studied by combining turning behaviour and c-fos expression

Neuroscience and Biobehavioral Reviews

Volumn 21, Issue 4, 1997, Pages 505-509

  Morelli, M ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Basal ganglia; C Fos; D1 receptor; Dopamine; Glutamate; NMDA; Parkinson; Sensitization

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; OXIDOPAMINE;

ARTICLE; BASAL GANGLION; DOPAMINERGIC SYSTEM; LOCOMOTION; NEUROTRANSMISSION; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RECEPTOR BLOCKING; REGULATORY MECHANISM;

EID: 0031006757     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(96)00031-0     Document Type: Article

References (36)

1. 1 receptor stimulation on rotation and c-fos expression. Eur. J. Pharmacol., 235, 167-168 1993.
2. 2. Barone, P.; Morelli, M.; Popoli, M.; Cicarelli, G.; Campanella, G.; Di Chiara, G., Behavioural sensitization in 6-hydroxydopamine lesioned rats involves the dopamine signal transduction: changes in DARPP-32 phosphorylation. Neuroscience, 61, 867-873 1994.
3. 3. Brotchie, J. M.; Mitchell, I. J.; Sambrook, M. A.; Crossman, A. R., Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate. Movement Disord., 6, 433-452 1991.
4. 4. Criswell, H.; Mueller, R. A.; Breese, G. R., Priming of D-1-dopamine receptor responses: long-lasting behavioral supersensitivity to a D-1 dopamine agonist following repeted administration to neonatal 6-OHDA-lesioned rats. J. Neurosci., 9, 125-153 1989.
5. 5. Danysz, W.; Parsons, C. G.; Bresink, I.; Quack, G., Glutamate in CNS disorders. Drug New Perspect., 8, 265-277 1995.
6. 6. Dragunow, M.; Faull, R., The use of c-fos as a metabolic marker in neuronal pathway tracing. J. Neurosci., 29, 261-265 1989.
7. 7. Engber, T. M.; Marin, C.; Suzel, Z.; Chase, T. N., Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding. Eur. J. Pharmacol., 236, 385-393 1993.
8. 8. Engber, T. M.; Susel, Z.; Kuo, S.; Gerfen, C. R.; Chase, T. N., Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats. Brain Res., 552, 113-119 1991.
9. 9. Ennulat, D. J.; Babb, S. M.; Cohen, B. M., Persistent reduction of immediate early gene mRNA in rat forebrain following single or multiple doses of cocaine. Molec. Brain Res., 26, 106-112 1994.
10. 10. Gancher, S.; Mayer, A., Sensitization to apmorphine-induced rotational behavior in 6-OHDA-lesioned rats: effects of NMDA antagonists on drug response. Brain Res., 682, 63-68 1995.
11. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science, 250, 1429-1432 1990.
12. 2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK 801. J. Neural Transm., 4, 15-26 1992.
13. 13. Kalivas, P. W.; Stewart, J., Dopamine transmission in the initiation and expression of drug-and stress-induced sensitization of motor activity. Brain Res. Rev., 16, 223-244 1991.
14. 14. Klockgether, T.; Turski, L., NMDA antagonists potentiate antiparkinsonian actions of L-DOPA in monoamine-depleted rats. Ann. Neurol., 28, 539-546 1990.
15. 15. Levesque, D.; Diaz, G.; Pilon, C.; Matres, M.; Giros, B.; Souil, E.; Schott, D.; Morgat, J.; Schwartz, J.; Sokoloff, P., Identification, characterization and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc. Natn. Acad. Sci. USA, 89, 8155-8159 1992.
16. 1 receptor-adenylate cyclase complex after priming. Eur. J. Pharmacol., 180, 365-367 1990.
17. 17. Morelli, M.; Di Chiara, G., Agonist-induced homologous and heterologous sensitization to D-1 and D-2 dependent contraversive turning. Eur. J. Pharmacol., 141, 101-107 1987.
18. 18. Morelli, M.; Di Chiara, G., Stereospecific blockade of N-methyl-D-aspartate transmission by MK 801 prevents priming of SKF 38393-induced turning. Psychopharmacology, 101, 287-288 1990.
19. 2 responses in the 6-hydroydopamine model of Parkinson's disease. Eur. J. Pharmacol., 182, 611-612 1990.
20. 1, dependent contralateral turning and its relationship to c-fos expression in the rat caudate-putamen. Behav. Brain Res., 79, 93-100 1996.
21. 21. Morelli, M.; Fenu, S.; Di Chiara, G., Behavioural expression of D-1 receptor supersensitivity depends on previous stimulation of D-2 receptors. Life Sci., 40, 245-251 1987.
22. 22. Morelli, M.; Fenu, S.; Pinna, A.; Cozzolino, A.; Carta, A.; Di Chiara, G., "Priming" to dopamine agonist-induced contralateral turning as a model of non-associative sensitization to the expression of the postsynaptic dopamine message. Behav. Pharmacol., 4, 389-397 1993.
23. 2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression. J. Pharmacol. Exp. Ther., 260, 402-408 1992.
24. 24. Morgan, J.I.; Curran, T., Stimulus-transcription coupling in neurons: role of cellular immediate-early genes. Trends Neurosci., 12, 343-349 1989.
25. 25. Ossowska, K., The role of excitatory amino acids in experimental models of Parkinson's disease. J. Neural Transm., 8, 39-71 1994.
26. 1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity. Neuroscience, 66, 347-359 1995.
27. 27. Paul, M. L.; Graybiel, A. M.; David, J. C.; Robertson, H. A., D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J. Neurosci., 12, 3729-3742 1992.
28. 28. Pontieri, F.; Morelli, M.; Orzi, F.; Terenzi, R.; Di Chiara, G., Metabolic mapping of the synergism between MK-801 and SKF 38393 in rats with unilateral lesions of the dopaminergic nigrostriatal pathway. Synapse, 12, 255-260 1992.
29. 29. Porter, R. H. P.; Greene, J. G.; Higgins, D. S. Jr; Greenamyre, J. T., Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion. J. Neurosci., 14, 7192-7199 1994.
30. 1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behaviour. Brain Res., 503, 346-349 1989.
31. 31. Robinson, T. E.; Becker, J. B., Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev., 11, 157-198 1986.
32. 32. Sagar, S. M.; Sharp, F. R.; Curran, T., Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science, 240, 1328-1331 1988.
33. 33. Schmidt, W. J.; Bubser, M.; Hauber, W., Behavioural pharmacology of glutamate in basal ganglia. J. Neural Transm., 38, 65-89 1992.
34. 34. Stewart, J.; Druhan, P., Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA reception antagonist, MK 801. Psychopharmacology, 110, 125-132 1993.
35. 35. Svensson, A.; Carlsson, A.; Carlsson, M. L., Differential locomotor between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice. J. Neural Transm., 90, 199-217 1992.
36. 36. Wachtel, H.; Kunow, M.; Löschmann, P.-A., NBQX (6-nitro-sulfamoyl-benzo-quinoxaline-dione) and CPP (3-carboxy-piperazin-propyl phosphonic acid) potentiate dopamine agonist induced rotations in substantia nigra lesioned rats. Neurosci. Lett., 142, 179-182 1992.